Our finding that β-arrestin2 mediates metastasis and invasion inhibition by altering E-cadherin, vimentin and p-Akt expression raised the possibility that β-arrestin2 prohibits Akt signalling activation and suppresses EMT, thereby reducing HCC cell invasion and metastasis. Here, CDH1 is linked to hepatocellular carcinoma.